Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor

Diabetes

Volumn 46, Issue 9, 1997, Pages 1473-1480

  Aiello, Lloyd Paul ^a   Bursell, Sven Erik ^a   Clermont, Allen ^a   Duh, Elia ^a   Ishii, Hidehiro ^a   Takagi, Chikako ^a   Mori, Fumi ^a   Ciulla, Thomas A ^d   Ways, Kirk ^e   Jirousek, Michael ^e   Smith, Lois E H ^a,b   King, George L ^a,c,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Children's Hospital

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d INDIANA UNIVERSITY   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVATION; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION;

EID: 15644366961     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.9.1473     Document Type: Article

References (40)

1. Aiello LP, Cavallerano J, Bursell S-E: Diabetic eye disease. Endocrinol Metab Clin North Am 25:271-291 1996
2. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Wisconsin Epidemiologic Study of Diabetic Retinopathy for Diabetic Macular Edema, report 4. Ophthalmology 91:1464-1474 1984
3. Aiello LP, Avery RL, Arrigg PG, Keyt B, Aiello LM, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
4. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Pouet J: Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 12:1476-1482, 1994
5. Adamis AP, Miller JW, Bernai MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450, 1994
6. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH: Inhibition of vascular endothelial growth factor suppresses retinal neovascularization in vivo. Proc Natl Acad Sci USA 92:10457-10461, 1995
7. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905-909, 1995
8. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR: Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 37:855-868, 1996
9. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574-584, 1994
10. Stone J, Chang-Ling T, Pe're J, Itin A, Gnessin H, Keshet E: Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthal Vis Sci 37:290-299, 1966
11. Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF: Correlation of vascular permeability/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol 114:1210-1217, 1996
12. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989
13. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113:1538-1544, 1995
14. Yang Q, Zwijsen A, Siegers H, Vanden Berghe D: Purification and characterization of VEGF/VPF secreted by human retinal pigment epithelial cells. Endothelium 2:73-85, 1994
15. Simorre P, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, Plouet J: Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci 35:3393-3400, 1994
16. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL: Comparative analysis of vascular endothelial growth factor (VEGF) receptors on retinal and aortic microvascular endothelial cells. Diabetes 44:98-103, 1994
17. Takagi H, King GL, Aiello LP: Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45:1016-1023, 1996
18. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, Plouet J: Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 164:385-394, 1995
19. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LEH: Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93:4851-4856, 1996
20. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW: Inhibition of VEGF prevent ocular neovascularization in a non-human primate. Arch Ophthalmol 114:66-71, 1996
21. Pu X, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek J, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms and endothelial cell growth. J Clin Invest 98:2018-2026, 1996
22. Senger D, Connolly D, Van De Water L, Feder J, Dvorak H: Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50:1774-1778, 1990
23. Collins PD, Connolly DT, Williams TJ: Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 109:195-199, 1993
24. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H: Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27:48-52, 1995
25. Vinores SA, Kuchle M, Mahlow J, Chiu C, Green WR, Campochiaro PA: Blood-ocular barrier breakdown in eyes with ocular melanoma: a potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol 147:1289-1297, 1995
26. Hughes A: A schematic eye for the rat. Vision Res 19:569-588, 1978
27. Heasley LE, Johnson GL: Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells. J Biol Chem 264:8646-8652, 1989
28. Xia P, Kramer RM, King GL: Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 96:733-740, 1995
29. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
30. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
31. Toker A, Meyer M, Reddy KK, Falck JR, Aneja R, Aneja S, Parra A, Burns DJ, Ballas LM, Cantley LC: Activation of protein kinase C family members by the novel polyphosphoinositides ptd1ns-3,4-P2 and ptdns-3,4,5-P3. J Biol Chem 269:32358-32367, 1994
32. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell SE: Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci 35:981-990, 1994
33. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31, 1995
34. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM: Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 43:381-389, 1995
35. Zeimer RC, Blair NP, Cunha-Vaz JG: Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol 101:1753-1756, 1983
36. Bursell SE, Delori FC, Yoshida A, Parker JS, Collas GD, McMeel JW: Vitreous fluorophotometric evaluation of diabetics. Invest Ophthalmol Vis Sci 25:703-710, 1984
37. Krupin T, Waltman SR, Oestrich C, Santiago J, Ratzan S, Kilo C, Becker B: Vitreous fluorophotometry in juvenile-onset diabetes mellitus. Arch Ophthalmol 96:812-814, 1978
38. Blair NP, Jones CW, Rusin MM: Pathophysiology of the blood-retinal barrier in experimental diabetes. Arch Ophthalmol 102:1810-1814, 1984
39. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH III, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, Faul MM: (S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4,h][1,4,13]oxa-diazacyclohexadecene-1,3(2H)-dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase Cβ. J Med Chem 39:2664-2671, 1996
40. Early Treatment Diabetic Retinopathy Study Report 9: Early photocoagulation for diabetic retinopathy. Ophthalmology 98:766-785, 1991